Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,848
Closed -$148K 1227
2025
Q1
$148K Buy
+11,848
New +$195K ﹤0.01% 881
2023
Q1
Sell
-24,976
Closed -$145K 1611
2022
Q4
$145K Buy
+24,976
New +$156K ﹤0.01% 1071
2021
Q1
Sell
-12,492
Closed -$212K 827
2020
Q4
$212K Buy
+12,492
New +$307K 0.01% 483
2019
Q4
Sell
-14,826
Closed -$205K 347
2019
Q3
$205K Buy
+14,826
New +$163K 0.03% 186
2019
Q1
Sell
-7,274
Closed -$60K 296
2018
Q4
$60K Buy
+7,274
New +$83.4K 0.01% 285
2018
Q2
Sell
-8,429
Closed -$97K 330
2018
Q1
$97K Buy
+8,429
New +$101K 0.01% 267
2016
Q2
Sell
-22,380
Closed -$431K 350
2016
Q1
$431K Buy
+22,380
New +$307K 0.04% 172

Other funds holding MESO

Old Mission Capital's MESO Position: Q2 2025 in Review

Old Mission Capital sold out of Mesoblast (MESO) in Q2 2025, closing a stake of 11,848 shares — an estimated $148K sold.

Old Mission Capital first reported a position in MESO in Q1 2016 and held it in 7 quarters. The position peaked at $431K in Q1 2016. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2025.

  • Old Mission Capital reported no remaining Mesoblast position as of Q2 2025 after selling out during the quarter.
  • Old Mission Capital sold 11,848 Mesoblast shares in Q2 2025, an estimated $148K.
  • Old Mission Capital first reported a position in Mesoblast in Q1 2016 and held it in 7 quarters.
  • Old Mission Capital's Mesoblast position peaked at $431K in Q1 2016.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2025.

Based on Old Mission Capital's 13F filing for Q2 2025, filed 14 Aug 2025.